Mycobacteriophage SWU1 gp39 can potentiate multiple antibiotics against Mycobacterium via altering the cell wall permeability

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Li, Qiming ^a   Zhou, Mingliang ^a   Fan, Xiangyu ^a,b   Yan, Jianlong ^a   Li, Weimin ^a   Xie, Jianping ^a  

^a SOUTHWEST UNIVERSITY   (China)

^b UNIVERSITY OF JINAN   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT; VIRAL PROTEIN;

CELL WALL; GENETICS; METABOLISM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PERMEABILITY; SIPHOVIRIDAE; VIROLOGY;

ANTITUBERCULAR AGENTS; CELL WALL; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PERMEABILITY; SIPHOVIRIDAE; VIRAL PROTEINS;

EID: 84976604111     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep28701     Document Type: Article

References (60)

1. Ren, H. & Liu, J. AsnB is involved in natural resistance of Mycobacterium smegmatis to multiple drugs. Antimicrobial agents and chemotherapy 50, 250-255 (2006).
2. Li, Q. et al. Proteasome Accessory Factor C (pafC) Is a novel gene Involved in Mycobacterium Intrinsic Resistance to broadspectrum antibiotics-Fluoroquinolones. Scientific reports 5, 11910 (2015).
3. Wolff, K. A. et al. Protein kinase G is required for intrinsic antibiotic resistance in mycobacteria. Antimicrobial agents and chemotherapy 53, 3515-3519 (2009).
4. Bowman, J. & Ghosh, P. A complex regulatory network controlling intrinsic multidrug resistance in Mycobacterium smegmatis. Molecular microbiology 91, 121-134 (2014).
5. Nandakumar, M., Nathan, C. & Rhee, K. Y. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis. Nature communications 5, 4306 (2014).
6. Lu, P. et al. The cytochrome bd-Type quinol oxidase is important for survival of Mycobacterium smegmatis under peroxide and antibiotic-induced stress. Scientific reports 5, 10333 (2015).
7. Berney, M., Hartman, T. E. & Jacobs, W. R. A Mycobacterium tuberculosis cytochrome bd oxidase mutant is hypersensitive to bedaquiline. mBio. 5, e01275-01214 (2014).
8. Takayama, K., Wang, L. & David, H. L. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 2, 29-35 (1972).
9. Zhang, Y., Heym, B., Allen, B., Young, D. & Cole, S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358, 591-593 (1992).
10. Banerjee, A. et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263, 227-230 (1994).
11. Rozwarski, D. A., Grant, G. A., Barton, D. H., Jacobs, W. R. & Sacchettini, J. C. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 279, 98-102 (1998).
12. Zhang, Y. & Yew, W. Mechanisms of drug resistance in Mycobacterium tuberculosis [State of the art series. Drug-resistant tuberculosis. Edited by Chiang, C. Y. Number 1 in the series]. The International Journal of Tuberculosis and Lung Disease 13, 1320-1330 (2009).
13. Vilcheze, C., Jacobs, J. & William, R. The mechanism of isoniazid killing: clarity through the scope of genetics. Annu Rev Microbiol. 61, 35-50 (2007).
14. Vilcheze, C. & Jacobs, J. R. W. R. Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities. Microbiology Spectrum 2, MGM2-0014-2013 (2014).
15. Loessner, M. J. Bacteriophage endolysins-current state of research and applications. Current opinion in microbiology 8, 480-487 (2005).
16. Huang, G. et al. Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1). BMC infectious diseases 14, 681 (2014).
17. Grover, N., Paskaleva, E. E., Mehta, K. K., Dordick, J. S. & Kane, R. S. Growth inhibition of Mycobacterium smegmatis by mycobacteriophage-derived enzymes. Enzyme and microbial technology 63, 1-6 (2014).
18. Lai, M.-J. et al. Antimycobacterial Activities of Endolysins Derived From a Mycobacteriophage, BTCU-1. Molecules 20, 19277-19290 (2015).
19. Catalao, M. J., Milho, C., Gil, F., Moniz-Pereira, J. & Pimentel, M. A second endolysin gene is fully embedded in-frame with the lysA gene of mycobacteriophage Ms6. PLoS ONE 6, e20515 (2011).
20. Gil, F. et al. Mycobacteriophage Ms6 LysB specifically targets the outer membrane of Mycobacterium smegmatis. Microbiology 156, 1497-1504 (2010).
21. Pohane, A. A., Joshi, H. & Jain, V. Molecular Dissection of Phage Endolysin an interdomain interaction confers host specificity in lysin a of mycobacterium phage D29. Journal of Biological Chemistry 289, 12085-12095 (2014).
22. Ronayne, E. et al. P1 Ref Endonuclease: A Molecular Mechanism for Phage-Enhanced Antibiotic Lethality. PLoS genetics 12, e1005797-e1005797 (2016).
23. Fan, X., Teng, T., Wang, H. & Xie, J. Biology of a novel mycobacteriophage, SWU1, isolated from Chinese soil as revealed by genomic characteristics. Journal of virology 86, 10230-10231 (2012).
24. Fan, X. et al. Genomic and proteomic features of mycobacteriophage SWU1 isolated from China soil. Gene. 561, 45-53 (2015).
25. Pawelczyk, J. & Kremer, L. The molecular genetics of mycolic acid biosynthesis. Microbiology Spectrum 2, MGM2-0003-2013 (2014).
26. Salzman, V. et al. Transcriptional regulation of lipid homeostasis in mycobacteria. Molecular microbiology 78, 64-77 (2010).
27. Dwyer, D. J. et al. Antibiotics induce redox-related physiological alterations as part of their lethality. Proceedings of the National Academy of Sciences 111, E2100-E2109 (2014).
28. Bass, D. et al. Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation. The Journal of Immunology 130, 1910-1917 (1983).
29. Brandt, R. & Keston, A. S. Synthesis of diacetyldichlorofluorescin: A stable reagent for fluorometric analysis. Analytical biochemistry 11, 6-9 (1965).
30. Costerton, J. W., Stewart, P. S. & Greenberg, E. Bacterial biofilms: A common cause of persistent infections. Science 284, 1318-1322 (1999).
31. Yu, J. et al. Both phthiocerol dimycocerosates and phenolic glycolipids are required for virulence of Mycobacterium marinum. Infection and immunity 80, 1381-1389 (2012).
32. Dharmaraja, A. T., Alvala, M., Sriram, D., Yogeeswari, P. & Chakrapani, H. Design, synthesis and evaluation of small molecule reactive oxygen species generators as selective Mycobacterium tuberculosis inhibitors. Chemical Communications 48, 10325-10327 (2012).
33. Royet, J., Gupta, D. & Dziarski, R. Peptidoglycan recognition proteins: modulators of the microbiome and inflammation. Nature Reviews Immunology 11, 837-851 (2011).
34. Kashyap, D. R. et al. Peptidoglycan recognition proteins kill bacteria by inducing oxidative, thiol, and metal stress. PLoS Pathogens 10, e1004280 (2014).
35. Fair, R. J. & Tor, Y. Antibiotics and bacterial resistance in the 21st century. Perspectives in medicinal chemistry 6, 25 (2014).
36. Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A. & Collins, J. J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797-810 (2007).
37. Koch, A., Mizrahi, V. & Warner, D. F. The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin? Emerging Microbes & Infections 3, e17 (2014).
38. Kohanski, M. A., Dwyer, D. J. & Collins, J. J. How antibiotics kill bacteria: from targets to networks. Nature Reviews Microbiology 8, 423-435 (2010).
39. Piccaro, G., Pietraforte, D., Giannoni, F., Mustazzolu, A. & Fattorini, L. Rifampin Induces Hydroxyl Radical Formation in Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 58, 7527-7533 (2014).
40. Li, G-q et al. Sublethal vancomycin-induced ROS mediating antibiotic resistance in Staphylococcus aureus. Bioscience reports 35, e00279 (2015).
41. Wu, X., Wang, X., Drlica, K. & Zhao, X. A toxin-Antitoxin module in Bacillus subtilis can both mitigate and amplify effects of lethal stress. PloS ONE 6, e23909-e23909 (2011).
42. Li, L. et al. Ribosomal Elongation Factor 4 Promotes Cell Death Associated with Lethal Stress. mBio. 5, e01708-e01714 (2014).
43. Vandal, O. H. et al. Acid-susceptible mutants of Mycobacterium tuberculosis share hypersusceptibility to cell wall and oxidative stress and to the host environment. Journal of bacteriology 191, 625-631 (2009).
44. Chuang, Y.-M. et al. Deficiency of the Novel Exopolyphosphatase Rv1026/PPX2 Leads to Metabolic Downshift and Altered Cell Wall Permeability in Mycobacterium tuberculosis. mBio. 6, e02428-02414 (2015).
45. Nguyen, H. T., Wolff, K. A., Cartabuke, R. H., Ogwang, S. & Nguyen, L. A lipoprotein modulates activity of the MtrAB twocomponent system to provide intrinsic multidrug resistance, cytokinetic control and cell wall homeostasis in Mycobacterium. Molecular microbiology 76, 348-364 (2010).
46. Cangelosi, G. A., Palermo, C. O. & Bermudez, L. E. Phenotypic consequences of red-white colony type variation in Mycobacterium avium. Microbiology 147, 527-533 (2001).
47. Pang, J. M. et al. The polyketide Pks1 contributes to biofilm formation in Mycobacterium tuberculosis. Journal of bacteriology 194, 715-721 (2012).
48. Lee, R., Brennan, P. & Besra, G. Mycobacterium tuberculosis cell envelope. Tuberculosis. Springer Berlin Heidelberg. 1-27 (1996).
49. Jankute, M., Cox, J. A., Harrison, J. & Besra, G. S. Assembly of the Mycobacterial Wall. Annual Review of Microbiology 69, 405-423 (2015).
50. Bisson, G. P. et al. Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampin-resistant, rpoB mutant Mycobacterium tuberculosis. Journal of bacteriology 194, 6441-6452 (2012).
51. Xu, W-x. et al. The Wag31 protein interacts with AccA3 and coordinates cell wall lipid permeability and lipophilic drug resistance in Mycobacterium smegmatis. Biochemical and biophysical research communications 448, 255-260 (2014).
52. Rodrigues, L., Ramos, J., Couto, I., Amaral, L. & Viveiros, M. Ethidium bromide transport across Mycobacterium smegmatis cellwall: correlation with antibiotic resistance. BMC microbiology 11, 35 (2011).
53. Torres-Barceló, C. & Hochberg, M. E. Evolutionary Rationale for Phages as Complements of Antibiotics. Trends in microbiology 24, 249-256 (2016).
54. Lu, T. K. & Collins, J. J. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proceedings of the National Academy of Sciences 106, 4629-4634 (2009).
55. Bauer, A., Kirby, W., Sherris, J. C. & Turck, M. Antibiotic susceptibility testing by a standardized single disk method. American journal of clinical pathology 45, 493 (1966).
56. Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNASeq. Nature methods 5, 621-628 (2008).
57. Anders, S., Pyl, P. T. & Huber, W. HTSeq-A Python framework to work with high-Throughput sequencing data. Bioinformatics 31, 166-169 (2014).
58. Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).
59. Lewis, T., Nichols, P. D. & McMeekin, T. A. Evaluation of extraction methods for recovery of fatty acids from lipid-producing microheterotrophs. Journal of Microbiological Methods 43, 107-116 (2000).
60. Luo, H. et al. Mycobacterium tuberculosis Rv1265 promotes mycobacterial intracellular survival and alters cytokine profile of the infected macrophage. Journal of Biomolecular Structure and Dynamics 34, 585-599 (2015).